SCHEMBL14366363

SCHEMBL14366363

CCOC(=O)[C@H](Cc1ccc(O[C@@H](C)[C@H](C)Oc2ccc(Oc3ccccc3)cc2)cc1)OC

nearest known ligand 0.56

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PPARG P37231 19/20 0.56
PPARA Q07869 18/20 0.56
PPARD Q03181 6/20 0.56
LMNA P02545 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5379589 0.91 PPARG (0.54) PPARGPPARAPPARDLMNAL3MBTL1
SCHEMBL14366349 0.91 PPARG (0.54) PPARGPPARAPPARDLMNAL3MBTL1
SCHEMBL5579135 0.88 PPARG (0.58) PPARGPPARAPPARD
SCHEMBL14366354 0.87 PPARG (0.72) PPARGPPARAPPARD
SCHEMBL5390329 0.87 PPARG (0.72) PPARGPPARAPPARD
SCHEMBL14366357 0.87 PPARG (0.72) PPARGPPARAPPARD
SCHEMBL14560773 0.86 PPARG (0.60) PPARGPPARAPPARD
SCHEMBL5390673 0.85 PPARA (0.73) PPARGPPARAPPARD
SCHEMBL5579003 0.85 PPARA (0.77) PPARGPPARAPPARD
SCHEMBL5379966 0.85 PPARA (0.77) PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070276138-A1 Modulators of peroxisome proliferator activated receptors BROOKS DAWN A 2007-11-29 US disclosed
US-20070276138-A1 Modulators of peroxisome proliferator activated receptors BROOKS DAWN A 2007-11-29 US disclosed
US-7192982-B2 Modulators of peroxisome proliferator activated receptors LIGAND PHARMACEUTICALS, INC. (US) 2007-03-20 US disclosed
US-7192982-B2 Modulators of peroxisome proliferator activated receptors LIGAND PHARMACEUTICALS, INC. (US) 2007-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070276138-A1 Modulators of peroxisome proliferator activated receptors PPARG, NCOA4, PPARA PPARG 1/4885PPARA 3/4885PPARD 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.